| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| T1015 |
Clinic visit/encounter, all-inclusive |
12,353 |
9,208 |
$994K |
| 99307 |
|
3,666 |
2,188 |
$146K |
| G0406 |
Follow-up inpatient consultation, limited, physicians typically spend 15 minutes communicating with the patient via telehealth |
1,172 |
641 |
$35K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
809 |
555 |
$29K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,373 |
3,715 |
$125.30 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
10,887 |
8,528 |
$83.06 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
540 |
464 |
$7.61 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
268 |
205 |
$0.12 |
| 81025 |
|
99 |
85 |
$0.00 |
| 82948 |
|
121 |
98 |
$0.00 |
| 81002 |
|
334 |
281 |
$0.00 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
85 |
66 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
34 |
26 |
$0.00 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
12 |
12 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
215 |
172 |
$0.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
565 |
423 |
$0.00 |
| J1094 |
Injection, dexamethasone acetate, 1 mg |
142 |
130 |
$0.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
94 |
82 |
$0.00 |
| 0011A |
|
91 |
40 |
$0.00 |
| 91301 |
|
71 |
25 |
$0.00 |